Gyre Therapeutics, Inc. Long-term Investments
Gyre Therapeutics, Inc. (GYRE) had Long-term Investments of $1.60 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:LongTermInvestments · last filed 2026-08-07
- 2026-06-30: Long-term Investments $1.60M.
- 2025-12-31: Long-term Investments $1.59M; Long-term Investments as first filed $1.60M.
- 2024-12-31: Long-term Investments $1.60M.
- 2020-12-31: Long-term Investments $2.54M.
| Period end | Long-term Investments | Long-term Investments as first filed |
|---|---|---|
| 2026-06-30 | $1.60M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $1.59M 10-Q · filed 2026-08-07 | $1.60M 10-K · filed 2026-03-13 |
| 2024-12-31 | $1.60M 10-K · filed 2026-03-13 | |
| 2020-12-31 | $2.54M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-05 | |
| 2015-09-30 | $825.00K 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |